Virginia Retirement Systems Et Al Shattuck Labs, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 16, 2023
SELL
$2.6 - $5.52 $78,000 - $165,600
-30,000 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$4.22 - $8.89 $57,392 - $120,904
13,600 Added 82.93%
30,000 $128,000
Q4 2021

Feb 03, 2022
BUY
$8.36 - $21.08 $137,104 - $345,712
16,400 New
16,400 $140,000

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $44.9M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email